Deutsche Bank’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Buy |
164,186
+10,689
| +7% | +$136K | ﹤0.01% | 1743 |
|
|
2025
Q4 | $1.38M | Buy |
153,497
+2,249
| +1% | +$31K | ﹤0.01% | 2017 |
|
|
2025
Q3 | $2.61M | Buy |
151,248
+8,380
| +6% | +$103K | ﹤0.01% | 1626 |
|
|
2025
Q2 | $1.34M | Sell |
142,868
-108,694
| -43% | -$893K | ﹤0.01% | 1920 |
|
|
2025
Q1 | $1.79M | Sell |
251,562
-939
| -0.4% | -$9.48K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $2.94M | Buy |
252,501
+27,282
| +12% | +$426K | ﹤0.01% | 1610 |
|
|
2024
Q3 | $4.63M | Buy |
225,219
+12,762
| +6% | +$294K | ﹤0.01% | 1308 |
|
|
2024
Q2 | $4.75M | Sell |
212,457
-1,619
| -0.8% | -$38.5K | ﹤0.01% | 1264 |
|
|
2024
Q1 | $5.89M | Sell |
214,076
-14,717
| -6% | -$409K | ﹤0.01% | 1198 |
|
|
2023
Q4 | $6.98M | Buy |
228,793
+87,619
| +62% | +$2.52M | ﹤0.01% | 1127 |
|
|
2023
Q3 | $4.46M | Sell |
141,174
-67,242
| -32% | -$2.61M | ﹤0.01% | 1072 |
|
|
2023
Q2 | $8.5M | Buy |
208,416
+46,180
| +28% | +$1.87M | ﹤0.01% | 1035 |
|
|
2023
Q1 | $6.05M | Buy |
162,236
+6,526
| +4% | +$256K | ﹤0.01% | 1158 |
|
|
2022
Q4 | $5.43M | Buy |
155,710
+9,044
| +6% | +$430K | ﹤0.01% | 1185 |
|
|
2022
Q3 | $8.21M | Buy |
146,666
+44,540
| +44% | +$2.76M | 0.01% | 1021 |
|
|
2022
Q2 | $5.29M | Sell |
102,126
-41,637
| -29% | -$2.11M | ﹤0.01% | 1250 |
|
|
2022
Q1 | $10.4M | Sell |
143,763
-40,031
| -22% | -$3.39M | ﹤0.01% | 1078 |
|
|
2021
Q4 | $21.7M | Buy |
183,794
+831
| +0.5% | +$104K | 0.01% | 834 |
|
|
2021
Q3 | $24.5M | Buy |
182,963
+13,116
| +8% | +$1.99M | 0.01% | 831 |
|
|
2021
Q2 | $27.5M | Buy |
169,847
+38,630
| +29% | +$3.01M | 0.01% | 804 |
|
|
2021
Q1 | $10.5M | Buy |
131,217
+20,500
| +19% | +$1.38M | 0.01% | 1168 |
|
|
2020
Q4 | $6.02M | Buy |
110,717
+75,752
| +217% | +$2.75M | ﹤0.01% | 1271 |
|
|
2020
Q3 | $694K | Sell |
34,965
-50,889
| -59% | -$1.06M | ﹤0.01% | 2440 |
|
|
2020
Q2 | $1.8M | Buy |
85,854
+12,460
| +17% | +$212K | ﹤0.01% | 1863 |
|
|
2020
Q1 | $897K | Sell |
73,394
-47,940
| -40% | -$646K | ﹤0.01% | 2150 |
|
|
2019
Q4 | $1.78M | Buy |
121,334
+9,397
| +8% | +$131K | ﹤0.01% | 2031 |
|
|
2019
Q3 | $1.49M | Sell |
111,937
-112,291
| -50% | -$1.79M | ﹤0.01% | 2083 |
|
|
2019
Q2 | $3.67M | Buy |
224,228
+167,707
| +297% | +$2.64M | ﹤0.01% | 1994 |
|
|
2019
Q1 | $963K | Sell |
56,521
-579,435
| -91% | -$8.64M | ﹤0.01% | 3014 |
|
|
2018
Q4 | $8.68M | Buy |
635,956
+172,309
| +37% | +$3.2M | 0.01% | 1404 |
|
|
2018
Q3 | $13.3M | Buy |
463,647
+142,480
| +44% | +$4.15M | 0.01% | 1412 |
|
|
2018
Q2 | $8.79M | Sell |
321,167
-31,197
| -9% | -$756K | ﹤0.01% | 1866 |
|
|
2018
Q1 | $7.43M | Buy |
352,364
+310,620
| +744% | +$7.64M | ﹤0.01% | 1879 |
|
|
2017
Q4 | $800K | Buy |
41,744
+3,279
| +9% | +$75.7K | ﹤0.01% | 3348 |
|
|
2017
Q3 | $954K | Buy |
38,465
+11,499
| +43% | +$217K | ﹤0.01% | 3052 |
|
|
2017
Q2 | $430K | Buy |
26,966
+25,074
| +1,325% | +$350K | ﹤0.01% | 3535 |
|
|
2017
Q1 | $25K | Sell |
1,892
-2,546
| -57% | -$34.2K | ﹤0.01% | 4441 |
|
|
2016
Q4 | $57K | Buy |
4,438
+1,617
| +57% | +$24.3K | ﹤0.01% | 4318 |
|
|
2016
Q3 | $47K | Sell |
2,821
-5,111
| -64% | -$98.9K | ﹤0.01% | 4237 |
|
|
2016
Q2 | $168K | Buy |
+7,932
| New | +$211K | ﹤0.01% | 3857 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
